Genetic Analysis announces preliminary outcome of the subsequent offering to existing shareholders

REG

Preliminary outcome of the Subsequent Offering

The preliminary outcome indicates that approximately 4,813,194 shares, corresponding to approximately 58 percent of the Subsequent Offering, have been subscribed (including oversubscription). Subscription was only allowed for holders of subscription rights. Subject to final results, the Subsequent Offering will provide the Company with proceeds of approximately NOK 4,1 million before deduction of costs related to the Subsequent Offering.

The issue of shares in the Subsequent Offering will be resolved by the Company's board of directors pursuant to an authorization to increase the Company's share capital granted by the Company's annual general meeting on May 19, 2025. Issuance and final allocation of shares in the Subsequent Offering to subscribers is expected to be resolved by the board of directors on or about June 18, 2025. The final outcome of the Subsequent Offering and further details on allocation and payment will be published shortly thereafter.

Advisors

In connection with the Subsequent Offering, Sedermera Corporate Finance AB (www.sedermera.se) is appointed Swedish financial advisor and Advokatfirmaet Wiersholm AS is the Company's Norwegian legal advisor.

Datum 2025-06-16, kl 16:30
Källa Cision
Alla Aktier tipsar: Har du redan ett konto på Avanza? Varför inte skapa ett på Nordnet också och jämföra funktioner, courtage mm. Det tar inte lång tid, du fixar det direkt här med BankID
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet